XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.24.3

Warrants | 9 Months Ended
--- | ---
Sep. 30, 2024
Warrants |
Warrants | Note 9 - Warrants The following table summarizes information with respect to outstanding warrants to purchase common stock during the nine months ended September 30, 2024: Schedule of Outstanding Warrants to Purchase Common Stock
|  |  |  |  |  |  |  | Weighted |  |  | Weighted |  |  |  |
|  |  |  |  |  |  |  | Average |  |  | Average |  |  | Aggregate |
|  | Warrants |  |  | Exercise |  |  | Remaining Life |  |  | Intrinsic |
|  | Outstanding |  |  | Exercisable |  |  | Price |  |  | In Months |  |  | Value |
Outstanding at December 31, 2023 |  |  | 635,314 |  |  |  | 635,314 |  |  | $ | 61.72 |  |  |  | 37 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | (17,529 | ) |  |  | (17,529 | ) |  | $ | 114.34 |  |  |  | - |  |  |  | - |
Outstanding at September 30, 2024 |  |  | 617,785 |  |  |  | 617,785 |  |  | $ | 60.23 |  |  |  | 29 |  |  |  | - |
The following table summarizes information about warrants outstanding at September 30, 2024: Schedule of Warrants Outstanding
|  |  | Warrants |  |  | Weighted Average |
Exercise price |  |  | Outstanding |  |  | Exercisable |  |  | Months Outstanding |
$ | 124.74 |  |  |  | 1,447 |  |  |  | 1,447 |  |  |  | 1 |
$ | 60.00 |  |  |  | 592,125 |  |  |  | 592,125 |  |  |  | 29 |
$ | 61.95 |  |  |  | 24,213 |  |  |  | 24,213 |  |  |  | 29 |
|  |  |  |  | 617,785 |  |  |  | 617,785 |  |  |  | 29 |
Q3 2021 Warrants Issued to Series B Preferred Stockholder On September 28, 2021, the Company entered into a Securities Purchase Agreement with an institutional investor, pursuant to which the investor purchased from the Company 3,300 shares of convertible Series B Preferred Stock with a stated value of $1,000 per share, or $3,300,000 of stated value in the aggregate, and a warrant to purchase up to 16,082 shares of common stock of the Company for an aggregate purchase price of $3,000,000. The warrant was exercisable until September 28, 2024, at an exercise price of $113.40, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights. Accordingly, these warrants expired, unexercised, on September 28, 2024. Q3 2021 Warrants Issued to Series B Preferred Placement Agent In connection with the sale of the shares of convertible Series B Preferred Stock described above, the Company issued 2,894 warrants to the placement agent and its designees. Half of the warrants were issued on September 28, 2021, and the second half were issued on November 3, 2021, and were exercisable commencing February 28, 2022 and May 3, 2022, respectively, until September 28, 2024 and November 3, 2024, respectively. The exercise price per share of the warrants was $124.80, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights. Accordingly, 1,447 of these warrants expired, unexercised, on September 28, 2024. Further, as discussed in Note 12 Subsequent Events below, the remaining 1,447 warrants expired unexercised on November 3, 2024. CEA Industries Inc. Notes to Condensed Consolidated Financial Statements September 30, 2024 (in US Dollars except share numbers) (Unaudited)

X
- References No definition available. + Details
Name: | CEAD_DisclosureWarrantsAbstract
Namespace Prefix: | CEAD_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants Disclosure [Text Block] + References No definition available. + Details
Name: | CEAD_WarrantsDisclosureTextBlock
Namespace Prefix: | CEAD_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration